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Abstract 
Network medicine is an emerging area of research dealing with molecular and genetic 
interactions, network biomarkers of disease, and therapeutic target discovery. Large-scale 
biomedical data generation offers a unique opportunity to assess the effect and impact of 
cellular heterogeneity and environmental perturbations on the observed phenotype. Marrying 
the two, network medicine with biomedical data provides a framework to build meaningful 
models and extract impactful results at a network level. In this review, we survey existing 
network types and biomedical data sources. More importantly, we delve into ways in which 
the network medicine approach, aided by phenotype-specific biomedical data, can be gainfully 
applied. We provide three paradigms, mainly dealing with three major biological network 
archetypes: protein-protein interaction, expression-based, and gene regulatory networks. For 
each of these paradigms, we discuss a broad overview of philosophies under which various 
network methods work. We also provide a few examples in each paradigm as a test case of its 
successful application. Finally, we delineate several opportunities and challenges in the field 
of network medicine. Taken together, the understanding gained from combining biomedical 
data with networks can be useful for characterizing disease etiologies and identifying 
therapeutic targets, which, in turn, will lead to better preventive medicine with translational 
impacts on personalized healthcare. 
 
 
1 Introduction 
Biological systems are comprised of various molecular entities such as genes, proteins and 
other biological molecules, as well as interactions between those components. Understanding 
a given phenotype, the functioning of a cell or tissue, etiology of disease, or cellular 
organization, requires accurate measurements of the abundance profiles of these molecular 
entities in the form of biomedical data. Analysis of the biomedical data allows us to explain 
important features of the interactions leading to a mechanistic understanding of the observed 
phenotype. The interplay between different components at different levels can be represented 
in the form of biological networks, for example, protein-protein interactions (PPI) (Cusick et 
al., 2005; Uetz et al., 2000) and gene regulatory networks (Davidson, 2006). Different 
biological networks capture the complex interactions between genes, proteins, RNA molecules, 
metabolites and genetic variants in the cells of organisms. These networks, also 
interchangeably known as graphs, are representations in which the complex system 
components are simplified as nodes that are connected by links (edges) (Vidal et al., 2011). 
Networks provide a conceptual and intuitive framework to model different components of 
multiple omics data from the genome, transcriptome, proteome, and metabolome (Figure 1) 
(Liu and Lauffenburger, 2009).  
The convenient representation of the biological components in graphs led to the field of 
network biology - a discipline that studies holistic relationships between various biological 
components by combining graph theory, systems biology, and statistical analyses (Lindfors, 
2011; Walhout et al., 2012). Moreover, the quantitative tools of network biology offer the 
potential to understand cellular organization and capture the impact of perturbations on these 
complex intracellular networks (Wang et al., 2011). Network Medicine is an extension of 
network biology with a set of focused goals related to disease biology, including understanding 
disease etiology, identifying potential biomarkers, and designing therapeutic interventions, 
including drug targets, dosage, and synergism discovery (Loscalzo et al., 2017). Research in 
network medicine heavily depends on large datasets for building models, making predictions 
and assessing their validity. The promise of network medicine research is to develop a more 
global understanding of how perturbations propagate in the system by identifying the 
pathways, sub-types of disease states, and key components in the networks that can be targeted 
in clinical interventions. Moreover, networks are the centerpiece of the ‘new biology’ in the 
biomedical data revolution and translation to personalized medicine (Schadt and Bjorkegren, 
2012). 
Advances in high-throughput biotechnologies have led to the generation of massive amounts 
of biomedical data that provides new research avenues. The rapid decline in costs due to 
technological advancements such as next-generation sequencing (NGS) have provided the 
necessary impetus to generate multiple large-scale multi-omics biomedical data-sets that 
characterize various phenotypes. This includes exome and whole genome sequencing, 
transcriptomics, proteomics, lipidomics, microbiomics etc. (Schadt and Bjorkegren, 2012). 
Constructing appropriate network models is a challenging problem that heavily depends on the 
study design, the phenotype under study, the molecular entities measured, and the type and size 
of the data. The field of network medicine is largely discovery —  rather than hypothesis — 
driven, uncovering previously unknown relationships and leading to the identification of new 
biomarkers. The statistical rigor of network predictions comes from the study design and the 
size of the datasets. Large-scale consortium-based efforts looking at the various aspects of 
human biology have allowed the application of network-based methods to uncover new 
insights into the molecular mechanisms of the given phenotype, such as tissue specificity or 
disease context.  In this review, we first examine various large-scale biomedical datasets and 
types of biological networks as summarized by Figure 1. We then provide three paradigms in 
which biological networks can be combined with big biomedical data to understand the given 
phenotype. 
2 Biomedical data sources  
Recent technological advancements in sequencing technologies, resulting in a reduction in cost 
per base pair, have heralded an era of massive data generation for different types of molecular 
profiles across a broad range of phenotypes and diseases. After the completion of the human 
genome project (Collins et al., 2003), HapMap project (International HapMap, 2003) created 
an extensive catalogue of common human genetic variants, the differences in DNA sequences, 
based on microarray data.  These studies eventually progressed into the ‘1000 Genomes 
Project’ (Genomes Project et al., 2015), which leveraged NGS technologies. In cancer research, 
The Cancer Genome Atlas (TCGA) (Cancer Genome Atlas Research, 2008) contains profiles 
of tumors and matched normal samples from more than 11000 subjects for 33 cancer types. 
The repertoire of TCGA data includes clinical information (demographic, treatment, and 
survival information), gene expression profiling, microRNA profiling, copy number variation 
(CNV) (genomic structural variations) identifications, single nucleotide polymorphism (SNP), 
DNA methylation (whole genome methylation calls for each CpG site), and exon sequencing 
(expression signal of particular composite exon of a gene). Together these data have helped in 
the identification of driver somatic mutations, the molecular basis of cancer progression, and 
potential therapeutic interventions for cancer subtypes. To understand the role of the epigenetic 
state in gene regulation and to characterize the functional elements of the transcriptional 
machinery, the Encyclopedia of DNA Elements (ENCODE) consortium for humans 
(Consortium, 2012), model organism Encyclopedia of DNA Elements (modENCODE) for 
model organisms (Yue et al., 2014), and ROADMAP Epigenomics project (Romanoski et al., 
2015) were commissioned to improve the understanding of how epigenomics contributes to 
disease. The Riken-led Functional ANnoTation Of Mammalian genome (FANTOM5) 
(Andersson et al., 2014) project provided cell-type-specific enhancer elements and identified 
pathobiological regulatory SNPs. To further understand transcriptional patterns in human 
tissues and their relationship with the genotype, Genotype-Tissue Expression (GTEx) data was 
generated (Consortium, 2015; Mele et al., 2015). Trans-Omics for Precision Medicine 
(TOPMed) (Prokopenko et al., 2018) is another set of multi-omics data on 100k individuals 
that also includes clinical data and is aimed at understanding the fundamental biological 
processes that underlie heart, lung, blood, and sleep disorders. The Precision Medicine 
Initiative or “All of Us” program (https://allofus.nih.gov/) aims to acquire a broad range of data 
from about 1 million individuals.  
Since 2003, the Human Protein Atlas (HPA) (Uhlen et al., 2005; Uhlen et al., 2015) by Swedish 
consortium has been releasing data on protein expression levels in cells, tissues, and various 
pathologies, including 17 cancer types. Similarly, the Human Cell Atlas (HCA) (Rozenblatt-
Rosen et al., 2017) aims to provide a reference map of single cell omics data in human cells 
and cell types. The UK-Biobank (Allen et al., 2014; Sudlow et al., 2015) is another commercial 
resource that has an array of health-related measurements on patients, including biomarkers, 
images, clinical information, and genetic data. The Human Microbiome Project (HMP) 
(Turnbaugh et al., 2007) is a categorization of microbiota on different human body sites whose 
goal is to understand the role of the microbiome and the impact of its dysbiosis on human 
disease. Apart from these large international databases looking at one or more aspects of health 
or disease, many other resources from the concerted efforts over decades of data collection are 
also available. This includes the Nurses’ Health Study (Belanger et al., 1978; Colditz et al., 
2016), Health Professionals Follow-up Study (Grobbee et al., 1990), Framingham Heart Study 
(Dawber et al., 1951; Mahmood et al., 2014), and COPDGene (Pillai et al., 2009). This wealth 
of biomedical data not only allows for a deeper probing of the underlying biological systems, 
but also inspires the development of novel methods that can maximize the information that can 
be extracted from these data. The tools developed within the field of network medicine are 
highly versatile, enabling their customized application depending on the given biological or 
disease context.  
Collecting large-scale multi-time point data across multiple omics in different disease 
conditions is expensive and often not feasible, especially for human subjects. However, small-
scale longitudinal for a single omic, such as gene expression, is available in biomedical 
databases (Bouquet et al., 2016; Jung et al., 2015). High resolution mass spectrometry has also 
allowed for the collection of longitudinal proteome data, for example to test the effect of drugs 
(Fournier et al., 2010) or oxidative stress (Vogel et al., 2011) in yeast. A longitudinal multi-
omic dataset containing both human transcriptomic and proteomic information has been 
analyzed to study changes in molecular profiles (Chen et al., 2012). Multi-omic datasets such 
as this one allows us to probe the relationship between biological molecules based on the 
central dogma of biology, such as the connection between transcript abundance and protein 
levels (Liu et al., 2016; Marguerat et al., 2012). Longitudinal data is also amenable to temporal 
or dynamical network analysis, wherein one can evaluate the statistical dependence of the state 
of a network on the gene expression patterns from previous time steps (Dondelinger and 
Mukherjee, 2019; Kim and Kim, 2018). Kim et al. provide a summary of several methods to 
infer temporal regulatory relationships (Kim et al., 2014). 
In the next section, we will review some of the main types of biological networks constructed 
using high throughput molecular profiling, literature mining, or manual curation of scientific 
literature.  
 
3 Primer on biological networks 
Each network-based study has to primarily identify two things: what are the critical entities in 
the system under investigation (nodes), and what is the nature of the interactions between these 
entities (edges) (de Silva and Stumpf, 2005). This information often comes from multiple 
different data sources, dealing with the various facets of the biological system. For example, 
Protein-Protein Interactions (PPIs), also defined as the interactome, is a network of proteins 
and physical interactions between them (Cusick et al., 2005). These interactions can be 
obtained from yeast-2-hybrid assays (Li et al., 2004; Vidal and Fields, 2014), co-
immunoprecipitation (Lin and Lai, 2017), literature text-mining (Papanikolaou et al., 2015), 
3D structure (Lu et al., 2013), co-expression of genes (Bhardwaj and Lu, 2005), sequence 
homology (Shen et al., 2007), and other sources. Each of these data sources have both merits 
and demerits (Cusick et al., 2005). These networks inform us about the overall topological 
properties of protein interactions as well as the positions of specific proteins within this 
network. However, extracting phenotype specific (i.e. cell, tissue or disease-specific) 
information based on the PPI remains an open challenge and requires the development of novel 
ways of integrating biomedical data with these networks.  
Gene co-expression networks (GCNs) and gene regulatory networks (GRNs) often make direct 
use of phenotype-specific gene expression data in the network construction, with additional 
analysis required to extract meaningful biological information for the underlying phenotype. 
The availability of transcriptomic data for a wide range of phenotypes presents an opportunity 
to probe the patterns of molecular co-abundance, albeit with limitations concerning the 
interpretation of the biology. GCNs can be constructed in many ways, including information 
theoretic, regression-based, and Bayesian approaches (Butte and Kohane, 1999). Several 
common methods for constructing GCNs include Weighted Gene Co-expression Network 
Analysis (WGCNA) (Langfelder and Horvath, 2008), Context Likelihood of Relatedness 
(CLR) (Faith et al., 2007), Algorithm for the Reconstruction of Accurate Cellular Networks 
(ARACNe) (Margolin et al., 2006), Partial Correlation and Information Theory (PCIT) 
(Reverter and Chan, 2008), Gene Network Inference with Ensemble of Trees (GENIE3) 
(Huynh-Thu et al., 2010), Supervised Inference of Regulatory Networks (SIRENE) (Mordelet 
and Vert, 2008), and Gene CO-expression Network method (GeCON) (Roy et al., 2014). Gene 
regulatory networks (GRN) are a related type of network that attempts to look beyond the co-
abundance of gene expression and instead identify the influencing patterns of transcription 
factor genes over others in a mechanistic fashion (Marbach et al., 2012). Since transcriptional 
regulation depends on cis and trans-regulatory elements as well as transcription factor binding, 
GRNs often incorporate this information during model construction. Many methods with a 
modified definition of correlations have been proposed to infer GRNs. However, identifying 
the putative cis-regulatory sequences, such as those found in the promoter regions of genes, 
that are relevant for a specific biological context is important to enable the understanding of 
disease, tissue, or cell-specific regulatory perturbations. The location of TF binding to the DNA 
can be assayed using yeast-1-hybrid  (Deplancke et al., 2004), ChIP-Seq (Jaini et al., 2014), or 
inferred by other means (Mundade et al., 2014). However, the cost and other limitations 
involved in generating these data in a context-specific manner have meant that incorporating 
this information when constructing putative regulatory networks remains a challenge. 
Other types of biological networks include metabolic networks, which represent a collection 
of biochemical interactions between metabolites and enzymes (Terzer et al., 2009). Ecological 
networks, which represent biotic interactions, can also be applied to microbiome data, the 
collection of microbes’ genes, to construct microbiome networks (Bauer and Thiele, 2018; 
Coyte et al., 2015; Layeghifard et al., 2017; Rottjers and Faust, 2018). Together, genotype and 
transcriptomic data can be used to map genetic variants to genes and then summarized in an 
expression Quantitative Trait Loci (eQTL) network (Fagny et al., 2017; Platig et al., 2016). A 
network of immune cell communication has been constructed using high-resolution mass 
spectrometry-based proteomics data and was shown to exhibit social networks-like properties. 
Disease networks, also known as the diseasome, have been proposed; these networks connect 
diseases and disorders with disease genes based on Online Mendelian Inheritance in Man 
(OMIM) associations  (Boyadjiev and Jabs, 2000; Goh et al., 2007; Hamosh et al., 2002; 
Wysocki and Ritter, 2011; Zhang et al., 2011). Similarly, networks connecting symptoms with 
diseases have helped to shed light on the shared genetic associations between diseases (Zhou 
et al., 2014). Efforts to identify specific disease-causing genes, using genomic intervals 
obtained from linkage mappings or Genome-Wide Association Studies (GWAS), have been 
undertaken using hybrid heterogeneous networks. These hybrid networks often include a 
combination of disease-gene networks, generic or tissue-specific molecular networks such as 
PPIs or GCNs, and prior knowledge of disease similarities (Moreau and Tranchevent, 2012; 
Navlakha and Kingsford, 2010; Ni et al., 2016). Various network-based tools have been 
implemented in the gene prioritization problem (Li and Patra, 2010; Tian et al., 2017; Wu et 
al., 2008). All these aforementioned types of network biology approaches are particularly 
useful in understanding complex diseases, which result from multiple genetic factors and 
environmental influences (Moreau and Tranchevent, 2012). 
Analysis of biological networks also necessitates understanding their structural or topological 
properties. This includes the identification of important modulators, driver nodes, local 
network structures, and recurrent subgraphs in the network. Local connectivity properties such 
as degree and other centrality metrics can help to identify key molecular entities that dominate 
various network neighborhoods, such as hubs, bottlenecks, or core nodes. At the global level, 
properties like average path length, degree distribution, diameter, clustering coefficients, and 
controllability (Liu et al., 2011) help with the characterization and comparison of network 
topologies. Mesoscale measures such subgraphs or network motifs – recurrent patterns 
connecting a fixed number of nodes (typically 3 or 4) – are  considered fundamental 
components of biological networks (Milo et al., 2002). An extension of network motifs to 
include more nodes, or graphlets, has been used to analyze the interactome (Davis et al., 2015; 
Malod-Dognin et al., 2017; Przulj et al., 2004). Identifying the connectivity patterns enriched 
in a network (i.e. over-represented with respect to a null model) can help to compare, 
characterize, and discriminate between networks (Alon, 2007; Przulj, 2007; Shen-Orr et al., 
2002). These patterns are also commonly associated with control substructures that dominate 
information flow in the networks, especially in transcriptional regulatory, neuronal, and social 
networks.  
4 Integrating data with networks/Combining biomedical data with networks: 
challenges and ways  
The ultimate aim of inferring biological networks using biomedical data is to provide lab-
testable hypotheses by identifying biomolecular entities that play a crucial role in the observed 
phenotype (Figure 1). Detecting changes in abundance levels of these biomolecules and their 
interaction landscape in the context of a tissue, cell, or disease-specific environment requires 
both relevant data and the application of appropriate network analysis. Each biological network 
analysis has strengths and limitations based on how it incorporates phenotype specific data, 
and the research question being addressed (Altaf-Ul-Amin et al., 2014; Kanaya et al., 2014). 
In some cases, it is possible to identify a baseline network from general physical interactions 
between proteins, after which disease or phenotype-specific information from specific 
experiments can be overlaid to generate a more context-specific network.  
PPI networks provide a fabric of potential interactions between proteins, but phenotype-
specific interactions can only be added as an extra layer from separate biomedical data. The 
hypothesis behind analyzing such networks, combination of baseline PPI with disease 
information added as next step, is that the defects or mutations in only a few genes or proteins 
may propagate to other components in the network, and that this collection of affected genes 
constitute a critical module in the network (Schadt and Bjorkegren, 2012). Previous work along 
these lines has shown that these modules are not only structurally related but are also 
functionally relevant to the observed phenotype. This central tenet of network medicine from 
the interactome has been successfully tested for many diseases and other phenotypes (Goh et 
al., 2007; Huang et al., 2018b; Huttlin et al., 2017; Lim et al., 2006; Menche et al., 2015; Sahni 
et al., 2015; Sharma et al., 2013; Sharma et al., 2018a; Sharma et al., 2015; Taylor et al., 2009; 
Wang et al., 2018; Willsey et al., 2018) and has also led to novel drug-target discoveries (Guney 
et al., 2016; Luo et al., 2017; Yildirim et al., 2007) along with novel interactions between genes. 
Despite recent advances, the PPI is incomplete and inferring disease-specific interactions 
requires innovative strategies in order to overcome this discrepancy. 
GCNs are by definition context-specific, as they are constructed by calculating correlations in 
a given gene expression data set. In contrast, GRNs often are built starting from a baseline 
network composed of all potential interactions between transcription factors and genes. This 
baseline network can be derived from genetic sequence information and DNA-binding domain 
sequences within regulatory proteins, such that an interaction is inferred if a given gene’s 
promoter contains the binding motif of a particular TF. Disease or tissue-specific information 
then has to be integrated with this baseline prior network to obtain meaningful information 
about perturbations caused due to the disease. 
In this review, we explore PPI, GCNs, and GRNs, and also provide exemplar methods for each. 
Based on these three types of networks, we describe three complimentary philosophies and 
modus-operandi to embed phenotypic specific molecular information from biomedical data 
into a network framework, as shown in Figure 2. We present these paradigms to demonstrate 
that applying network phenomenology to big biomedical data requires a nuanced, condition-
specific approach. In the following sections, we will focus on each paradigm separately, 
providing their examples, the questions they intend to answer, and the diagnostics of the 
outcomes. We mainly focus on reviewing the methods to integrate multi-omic data to extract 
phenotype specific information, specifically the disease and tissue specificity in PPI, GCN, and 
GRN. 
 
4.1 PARADIGM I: Network-based approach to human disease using the 
interactome 
The high-throughput mapping of the interactome has provided a molecular interaction map of 
the genes encoding proteins that might drive an underlying pathophenotype (Barabasi et al., 
2011; Hein et al., 2015; Huttlin et al., 2015; Kamburov et al., 2009; Rolland et al., 2014; Zhang 
et al., 2013). Understanding disease associated biomedical data in the context of the network 
principles supports the discovery of more accurate biomarkers, localization of the disease 
perturbation in the network, personalized networks, better disease sub-type classifications, 
better targets for drug developments, and better drug repurposing. Using this paradigm, one 
can extract disease-specific signals in a variety of ways. One may consider topological 
properties of the nodes and assess the functional role of their hubness, i.e., a node property of 
having higher number of connections. Alternatively, one can also identify new disease genes 
in the network by using ‘guilt-by-association’ (Aravind, 2000; Huang et al., 2018b; Lage et al., 
2007; Lee et al., 2011; Quackenbush, 2003; Sharma et al., 2010; Sharma et al., 2013; Stuart et 
al., 2003) — a property ascribed not based on direct evidence but association with other disease 
genes, albeit with care (Gillis and Pavlidis, 2012). In addition to prioritizing candidate disease 
genes, molecular interaction networks can assist in identifying the sub-networks that are 
mechanistically linked to disease phenotypes (Emamjomeh et al., 2017; Menche et al., 2015; 
Sharma et al., 2015; van Dam et al., 2018). The proteins in these connected subnetworks may 
have clinical importance by being therapeutic targets and biomarkers (Sharma et al., 2015). 
Network tools can also provide a framework for disease classification (Halu et al., 2017; Zhou 
et al., 2018). 
Assessing disease genes from other, non-disease genes by their topological properties on the 
interactome have provided new insight into disease pathobiology. It was found that disease 
genes tend to have non-hub properties (Goh et al., 2007).  Later, it was reported that genes 
from OMIM and those associated with cancer are more central in a literature-curated 
interactome (Ideker and Sharan, 2008; Jonsson and Bates, 2006; Xu and Li, 2006). Further, 
several studies demonstrated that disease genes, in general, mostly have a high-degree and a 
low clustering coefficient (number of mutual connections with the neighboring nodes) (Cai et 
al., 2010; Feldman et al., 2008). Moreover, recently it was reported that disease genes have a 
higher degree, but it was discovered that the cancer-related genes are the primary drivers of 
this trend (Jonsson and Bates, 2006; Wachi et al., 2005). Genes associated with either 
Mendelian or complex diseases also have higher degree and lower clustering coefficients 
compared to non-disease genes (Cai et al., 2010; Pinero et al., 2016). The topological properties 
of disease-associated genes vary significantly from disease to disease. The factors that 
influence these discrepancies include the incompleteness of the current interactome, bias 
toward well-studied genes, and incomplete knowledge about the number genes associated with 
various diseases  (Menche et al., 2015). It is anticipated that the alliance of different 
technologies like yeast-2-hybrid, affinity purification mass-spectrometry (AP-MS), and cross-
linking AP-MS (Schweppe et al., 2018) will provide access to larger data that will be helpful 
in providing knowledge about the missing interactions. On the disease-gene discovery side, 
projects like the UK biobank prospective cohort study, which includes in-depth genetic and 
phenotypic data, will enhance knowledge regarding the missing disease genes (Bycroft et al., 
2018). 
An important area in which the interactome has helped in understanding complex diseases is 
the prediction of disease associated genes. The goal is to identify novel genes and proteins, 
which are involved in the regulation of tissues, or dysregulated in case of disease, through the 
association with observed disease candidate genes using the biological hierarchy of molecular 
interactions. Figure 2A depicts this paradigm where the PPI network serves as map of potential 
biological interactions between various proteins over which disease associates genes are 
mapped to uncover relevant biology. The central philosophy in most methods under this 
paradigm is that the neighbors of the disease associated components or network modules, such 
as a set of differentially expressed genes (Chuang et al., 2007) or genes with disease-associated 
SNPs (Barrenas et al., 2012; Feldman et al., 2008; Lage et al., 2007; Oti et al., 2006), could 
potentially be associated with similar diseases (Goh et al., 2007), and are closer to each other 
as compared to the other nodes in the network. The definition of this closeness, or vicinity of 
nodes, just like the definition of modules and clusters, varies with different research strategies. 
Some methods assume topological closeness in terms of the number of shortest paths 
connecting given nodes, while others take the similarity of biological function into account. 
Guilt-by-association methods focus on identifying new disease genes by optimizing based on 
both the local and global properties of the network and by considering the role of other disease 
genes and their neighborhood. Network-based strategies to find disease genes and their 
associated mechanisms can be divided in two types: exploratory and analytic methods (Carter 
et al., 2013). In exploratory methods one can analyze the biological trends due to perturbations. 
For example, Chu et al. expanded on known angiogenesis pathways to construct a protein-
protein interaction network for angiogenesis (Chu et al., 2012). In contrast, analytic methods 
aim to identify specific genes and pathways associated with a disease. For example, Gilman et 
al. developed a method for network-based analysis of genetic associations to identify a 
biological network of genes affected by rare de nova CNVs in autism (Gilman et al., 2011). 
Recently, Huang et al. systematically evaluated 21 protein-interactions networks for the ability 
to recover disease genes sets (Huang et al., 2018b). After correcting for size, they found that 
the Database for Interacting Proteins (DIP) network (Xenarios et al., 2000) had the highest 
efficiency in recovering disease genes (Huang et al., 2018b).  
In contrast to predicting the disease candidate proteins, finding the associated disease-related 
network components, or sub-networks, provides a more substantial network space to discover 
the pathways and mechanisms that influence disease. Goh et al. proposed a correlation between 
the location of disease-associated genes and the topology of the molecular interaction network 
(Goh et al., 2007). The tendency of disease-associated genes to interact more often with others 
compared to random genes in the interactome led to the establishment of the ‘local impact’ 
hypothesis (Barabasi et al., 2011).  According to this hypothesis, molecular entities involved 
in similar diseases have an increased tendency to interact with each other and to localize in a 
specific neighborhood of the interactome (Barabasi et al., 2011). The search for these modules 
involves exploring the structural and topological properties of the PPI network. Community 
detection algorithms (Spirin and Mirny, 2003), clique percolation (Sun et al., 2011), and 
genetic algorithms (Liu et al., 2018) have been applied to uncover disease modules using 
network properties (Vlaic et al., 2018). Module prediction and identifying non-overlapping 
clusters with the PPI remains challenging since the PPI network has a short diameter, i.e., most 
nodes are close to all other nodes in terms of network distance. Novel distance metrics and 
community detection algorithms have been proposed to overcome this problem (Hall-Swan et 
al., 2018). The recently proposed DIseAse MOdule Detection (DIAMOnD) algorithm 
(Ghiassian et al., 2015) associates the functional modules of known disease-associated proteins 
(seed proteins) and identifies the close neighbors of these genes (candidate disease-associated 
proteins) using topological properties of the interactome. The method suggests that the 
connectivity significance among the disease-associated proteins is the best predictive quantity 
to find the disease related components in the interactome. The underlying hypothesis is that 
close neighbors of known disease proteins may be involved in the disease. The working 
principle of DIAMOnD is as follows; first, a pool of disease genes encoding proteins is 
identified for a disease of interest from biological experiments, genome-wide association 
studies, linkage analysis, or other disease associated data sources (Pinero et al., 2017). Next, 
these disease proteins (seeds) are mapped onto the interactome. Next, neighbor proteins are 
added iteratively to the set of seed proteins based on the condition that each neighbor added is 
most significantly connected to the seed proteins. A hypergeometric test assigns a p-value to 
the proteins that share more connections with seed proteins than expected by chance. Finally, 
the seed proteins plus the added neighbor proteins are part of network components that 
represent a disease module, or a subnetwork of proteins in the interactome, the members of 
which are more functionally and topologically related to each other than to other portions of 
the network. These subnetworks are designated as disease-specific modules based on the 
source of initial seed proteins. Disease module identification has also led to endophenotypes, 
intermediate pathophenotypes, and network modules describing their common and distinctive 
molecular mediators (Ghiassian et al., 2016; Lage et al., 2008).  
As mentioned previously, significant progress has been made in mapping the interactome by 
high-throughput approaches like yeast-2-hybrid (Dreze et al., 2010; Rolland et al., 2014; Rual 
et al., 2005; Venkatesan et al., 2009), AP/MS (Hein et al., 2015; Huttlin et al., 2017; Huttlin et 
al., 2015) and various literature-curated data sources, such as ConsensusPathDB, STRING, and 
PCNet, which collate the known and predicted interactions between proteins (Klingstrom and 
Plewczynski, 2011).  Despite these efforts, the current interactome mapping is 80% incomplete 
(Hart et al., 2006; Menche et al., 2015; Mosca et al., 2013; Venkatesan et al., 2009) and is 
affected by many experimental and literature biases. Given the incompleteness of the 
interactome, it is possible that the disease modules are also far from complete. An attempt to 
overcome this limitation was made using a network-based closeness approach that compares 
the weighted distance between different disease and seed-gene neighborhoods to random 
expectation on the network. In the context of Chronic Obstructive Pulmonary Disease (COPD), 
140 potential candidate genes (Sharma et al., 2018) were identified. Another shortcoming of 
disease module detection related to the lack of context-dependence and tissue-specificity 
within the PPI was studied by (Kitsak et al., 2016). They found that the genes expressed in a 
particular tissue tend to form localized connected subnetworks, which overlap between similar 
tissues and are situated in the different neighborhoods for pathologically distinct pairs of 
tissues. The perturbations in tissue-dependent subnetworks may help us understand disease 
manifestations or pathophenotypes. Integrating multi-omics data, including epigenomics, 
proteomics, and metabolomics, with PPI analysis remains challenging, but is critical for 
identifying disease or tissue-specific modules in the interactome. 
4.2 PARADIGM II: Identifying important genes using patterns of co-abundance 
of biomolecules  
Measuring transcript abundance or gene expression patterns for given phenotypes (case-
control) across multiple samples is one of the main research strategies used to probe the system 
as it is connected to the central dogma of molecular biology. Performing differential gene 
expression analysis often identifies important genes affected by the disease. However, it does 
not provide information regarding how these genes are influenced by or influence other genes. 
It has been observed that genes with similar expression patterns might be part of complexes, 
influence each other, or be part of the same pathways or mechanisms (Serin et al., 2016). This 
inspired the construction of gene co-expression networks where the patterns of transcript 
abundance are studied in the context of the disease. The central philosophy of this paradigm is 
to combine important seed genes with an organic network of co-expression patterns derived 
from the gene expression data from the same system.  
There are many ways to compute co-expression or co-abundance patterns, including using 
Pearson correlations (Stuart et al., 2003),  Spearman rank correlations (Liesecke et al., 2018; 
Song et al., 2012), mutual information (Butte and Kohane, 1999; Margolin et al., 2006; Meyer 
et al., 2007), Gaussian graphical models (Toh and Horimoto, 2002), regression-based methods 
(Pirgazi and Khanteymoori, 2018; van Someren et al., 2006; Yeung et al., 2002), Bayesian 
approaches (Friedman et al., 2000; Li et al., 2007; Perrin et al., 2003; Xing et al., 2017), random 
matrix theory (Jalan et al., 2010; Jalan et al., 2012; Luo et al., 2007), and partial correlations 
(Reverter and Chan, 2008). Gene co-expression networks (GCNs) identify the functionally 
coordinated participation of genes in response to an external stimulus or condition. GCNs can 
be signed or unsigned, weighted or unweighted, and may either be constructed using 
microarray or RNA-Seq data. Care must be exercised when using thresholding methods to 
obtain unweighted co-expression networks as these are subjective and can change the network 
structure and topology (Elo et al., 2007); methods based on the clustering coefficient 
(Boyadjiev and Jabs, 2000), random matrix theory (Luo et al., 2007), or soft thresholding, 
which raises the weights by a certain power to penalize weaker edges (Langfelder and Horvath, 
2008), have been  used to address this limitation. Along with total gene expression levels, 
isoform abundance and alternative splicing can also be used in constructing gene co-expression 
networks (Saha et al., 2017).  
GCNs are also used to identify co-expression modules. Clusters, modules, or subgraphs of 
genes that have similar functions are often highly interconnected in GCNs. These clusters can 
be identified using network topology-based methods like community detection (Girvan and 
Newman, 2002), modularity maximization (Newman, 2004), K-means clustering (Stuart et al., 
2003), or variants of hierarchical clustering methods (Langfelder and Horvath, 2008; Serin et 
al., 2016). The genes in the most significant modules are then assessed for their biological 
importance using functional enrichment methods. The genes in the clusters are also often tested 
for their enrichment with differentially expressed genes from transcriptomic analysis, as 
illustrated in Figure 2B. Based on these results, other non-differentially-expressed genes in the 
enriched clusters can be implicated in the disease using ‘guilt-by-association’ approaches. The 
newly implicated genes may have clinical importance as potential therapeutic targets and 
biomarkers. 
Despite the aphorism “correlation is not causation”, partial yet informative insights can be 
gleaned from co-expression networks, such as underlying regulatory framework mediating the 
co-expression patterns. New methods based on partial-correlations, Bayesian, and graphical 
Gaussian models (Werhli et al., 2006) take into account local connectivity when estimating 
edge strengths and a few methods work by combining prior-knowledge of expression patterns 
of TFs with co-expression information (Huynh-Thu et al., 2010; Rotival and Petretto, 2014). 
Gene-gene interaction network methods like ARACNe (Margolin et al., 2006) and Context 
Likelihood of Relatedness (CLR) (Faith et al., 2007) attempt to better capture these regulatory 
associations by accounting for connections within a shared neighborhood of genes in order to 
infer the strength of a link between two genes. Applying these approaches in complex 
conditions, like a gene being regulated by many regulators, becomes more challenging. 
Inferring the direct regulatory influence of transcription factors on target genes is central to 
interpreting the regulatory networks. Concerted efforts to support network-inference, such as 
the DREAM5 benchmark challenge (Marbach et al., 2012), have summarized different 
strategies that can be employed to infer regulatory networks. The accuracy of reconstruction 
approaches is often tested by comparing the predicted networks with high-confidence 
transcription factor binding data (He and Tan, 2016). However, integrating multi-omic data 
into these models to understand the pathobiology of disease states is an open challenge. 
Methods like CellNet (Cahan et al., 2014) an extension of CLR, and MOGRIFY (Rackham et 
al., 2016) take into account differentially expressed genes within the co-expression network 
framework in order to predict cellular reprogramming by transcription factors. Thus, co-
expression methods have also been used to infer regulatory networks and to delineate the 
influence of regulatory genes, such as transcription factors, on their targets. However, obtaining 
condition-specific gene regulatory networks requires information regarding transcription factor 
binding activity in the given context. We will review methods that utilize TF binding 
information in the next section.  
To summarize, inferring disease-specific information from GCN is possible from co-expressed 
or co-regulated clusters, differentially expressed and co-expressed genes, as well as the 
topological and functional properties of these. Biomedical big data measuring the 
transcriptome is highly leveraged by GCNs. For example, human tissue-specific GCNs have 
been constructed and analyzed (Pierson et al., 2015) using consortium data such as GTEx (Mele 
et al., 2015). These analyses revealed that genes with tissue-specific function are not hubs but 
connect to tissue-specific transcription factor hubs. Explorations using relative isoform ratios 
(RNA transcripts from same genes with different exons removed) and splicing data revealed 
distinct co-expression relationships unique to the tissues (Saha et al., 2017). Tissue specificity 
of gene co-expression networks have also been assessed in rats (Xiao et al., 2014), humans 
(Farahbod and Pavlidis, 2018; Kogelman et al., 2016; Ni et al., 2016; Prieto et al., 2008; Xiao 
et al., 2014), bats (Rodenas-Cuadrado et al., 2015), and plants (Aravind, 2000). Similarly, 
TCGA data has been analyzed using WGCNA in order to study the system-level properties of 
prognostic genes (Yang et al., 2014). Similar to gene co-expression, protein co-abundance 
networks can also be used to pinpoint influential proteins as potential regulators of the observed 
phenotype, and have been used to study inflammation (Halu et al., 2018), HCV infections 
(McDermott et al., 2012), and cancer, including breast cancer (Ryan et al., 2017) and 
glioblastoma (Kanonidis et al., 2016). 
4.3 PARADIGM III: Inferring Phenotype specific Gene Regulatory Networks 
In the previous sections, we studied various ways to construct networks and integrate molecular 
data to extract phenotype-specific biology in the form of gene prioritization, disease modules, 
or therapeutic targets. Those included immutable PPIs allowing disease-specific information 
to be embedded onto them and organic ways to model disease-specific information using co-
expression networks. Here, separate networks are built for each phenotype which may be case-
control, disease-specific, tissue or cell-specific, sex-specific, or for different disease subtypes. 
The network comparison model stems from the axiom of ‘differential networking’ over 
‘differential expression.’ Many examples of differential networking can be found, including 
the INtegrated DiffErential Expression and Differential network analysis (INDEED) (Zuo et 
al., 2016) and DICER (Amar et al., 2013) algorithms. In this paradigm, we aim to discuss ways 
of leveraging phenotype-specific biomedical information to construct condition-specific gene 
regulatory networks. In principle, gene co-expression networks can also be phenotype-specific 
and can be used to infer condition-specific signals, but they lack the underlying set of canonical 
interactions unlike gene regulatory networks which include protein-DNA information in the 
form of TF binding information. 
Instead of combining data from cases and controls to obtain key molecular elements, such as 
differentially-expressed genes or genes annotated to GWAS SNPs, in this paradigm the data is 
used to construct separate networks for each of the conditions. This construction of phenotype 
specific networks helps to mitigate systematic experimental biases and errors in both conditions 
(de la Fuente, 2010; Ideker and Krogan, 2012). It allows the comparison of networks to help 
uncover the specific rewiring of pathways, such as those induced by disease, pharmacological 
treatment (Bandyopadhyay et al., 2010), or environmental stimuli. GCNs can also be 
constructed in a phenotype-specific manner, as seen in the previous section. In Figure 2C, we 
depict an approach where phenotype-specific networks are constructed to uncover 
differentially targeted interactions. In this section, we focus on transcriptional regulatory 
networks that depend not only on co-expression, but also on modeling the binding propensities 
of TFs. These networks may also incorporate other multi-omic data to obtain condition-specific 
regulatory models.  
The primary benefit of comparing phenotype-specific networks, particularly in GRNs, is to 
better delineate the role of genes in each condition. The ‘rewiring’ of the TFs targeting each of 
the genes can be tracked and the perturbations leading to these changes can convey information 
regarding the mechanistic underpinnings of the observed phenotype. An apt extension of 
‘differential networking’ to the transcriptional regulatory network framework is ‘differential 
targeting’, which captures the highly dynamic nature of gene regulation. Changes in network 
topology, driven by underlying condition-specific data, can yield valuable insights and help to 
identify driver nodes and network biomarkers, such as a set of strengthened or weakened 
interactions between TF and target genes in the context of disease.  
We review the Passing Attributes between Networks for Data Assimilation (PANDA) 
algorithm (Glass et al., 2013) as an exemplary method for constructing condition-specific 
regulatory networks, allowing for robust differential targeting analysis. PANDA is initiated by 
constructing a prior regulatory network consisting of potential routes for communication by 
mapping transcription factor motifs to a reference genome and assigning them to genes if they 
are in the regulatory region of the genes. PANDA then integrates other sources of information 
to iteratively optimize the flow of information through the network, modifying the prior to 
obtain a condition-specific regulatory network. The phenotype-specific regulatory networks 
are then compared to identify the structures most affected by this ‘rewiring’ and their biological 
significance. PANDA models the interactions between transcription factors based on the 
following principles. Firstly, if two transcription factors have a similar targeting profile, i.e., 
target similar genes or have binding motifs in the promoters of the same genes, they are more 
likely to physically interact or be members of the same TF complex (Guo et al., 2016; Hemberg 
and Kreiman, 2011). Cooperative binding of TFs is found to be evolutionarily constrained and 
conserved (Goke et al., 2011; He et al., 2011), and impacts crucial eukaryotic functions (He et 
al., 2011; Hochedlinger and Plath, 2009; Will and Helms, 2014; Wilson et al., 2010). Likewise, 
if two genes are targeted by the same set of TFs, these genes are likely to share similar 
expression patterns (Kim et al., 2006; Marco et al., 2009; Yu et al., 2003), or be part of the 
same functional module (Feldman et al., 2008; Goh et al., 2007). For this purpose, PANDA 
incorporates PPI networks to determine the ‘responsibility’ of TFs co-binding based on shared 
targets. It also uses GCNs to determine the ‘availability’ of genes to be simultaneously co-
regulated, as evidenced by common co-expression. A vital component in PANDA is a ‘prior’ 
network composed of all potential regulatory routes based on the existence of binding sites for 
TFs in the regulatory regions of genes. All three ingredients (PPI, GCN, and a network prior) 
are then assimilated to uncover consistent patterns among these networks using a message-
passing framework similar to affinity-propagation (Frey and Dueck, 2007). The outcome is a 
network elucidating the edges that form self-consistent modules, identifying relevant biological 
processes. 
The phenotype-specific applications of PANDA are broad and include the comparison of 
disease and control networks in both complex diseases and cancers. For example, PANDA has 
been used to identify potential drug targets in ovarian cancer subtypes (Glass et al., 2015). 
Comparing PANDA networks between poor and good responders to asthma therapies 
identified potential transcriptional mediators of corticosteroid response in asthma (Qiu et al., 
2018). The role of serotonin (5HT) dysregulation in mitral valve disease was explored using 
PANDA to find upregulation in 5HTR2B expression and increase 5HT receptor signaling 
(Driesbaugh et al., 2018). The effect of weight-loss on decreased risk of colorectal cancer was 
evaluated by applying PANDA to gene expression data on rectal mucosa biopsies (Vargas et 
al., 2016). In cancer research, PANDA network analysis in triple-negative breast cancer 
(TNBC) identified new core modules of functionally essential TFs and genes in cancer cells  
(Min et al., 2017). PANDA has also been used to investigate non-epithelial cancers like glioma 
to identify prognostic biomarkers mainly concerning mesenchymal signatures (Celiku et al., 
2017). Sexual dimorphism, where the phenotypes are males and females, is another area where 
PANDA has been applied extensively, from sex-related targeting differences in COPD (Glass 
et al., 2014), colorectal cancer (Lopes-Ramos et al., 2018), and understanding crucial sex-
related differences in various tissues in the human body (Chen et al., 2016). Differences 
between cell-lines and their host tissues have also been investigated using PANDA  (Lopes-
Ramos et al., 2017). 
The issue of tissue-specificity can also be addressed by the paradigm of condition-specific 
networks, where the phenotype is the tissue or cell type. Various methods use gene expression 
data with regression trees (Huynh-Thu et al., 2010) or consider the context of pathways 
(Jambusaria et al., 2018). Enhancer and promoter data (Marbach et al., 2016) have been used 
to construct tissue-specific networks in humans and plants (Huang et al., 2018a). Using GTEx 
transcriptome data, PANDA has been used to construct gene regulatory networks for 38 distinct 
human tissues  (Sonawane et al., 2017). This analysis assessed the inter-relationship between 
tissue-specific genes and TFs based on expression data and tissue-specific interactions and the 
topological positions of functionally important genes in respective tissues. This study also used 
network centrality measures like betweenness and degree to assess the topological properties 
of the nodes to identify rewiring around these genes in various tissues. Another significant 
contribution of this work is the elucidation of the tissue-specific regulatory roles of 
transcription factors, which were found to be independent of their expression levels. Instead, 
transcription factors appeared to mediate critical tissue-specific processes through subtle shifts 
in the gene regulatory networks, providing functional redundancy and, as a consequence, 
phenotypic stability of tissues.   
5 Conclusion and future directions 
Above we reviewed a limited set of network medicine philosophies that seek to integrate 
biomedical big data to uncover meaningful biology. Network medicine approaches provide 
customized and optimized ways to leverage biomedical data. The choice of these appropriate 
network method is largely dictated by the underlying biological inquiry, hypotheses, study 
design, and available data. Although this review is not meant to be exhaustive, our intent was 
to give a essence of how biomedical data requires a nuanced approach when selecting network 
analyses and provide a resource for both network scientists and biologists to better understand 
the lexicon of network modeling of biomedical data.  
We believe that network medicine approaches will be vital in the future with the increasing 
emergence of diverse technologies, multi-omic data types, deeper levels of inquiry from tissues 
to cellular levels, platforms that include large amounts of publicly available biomedical data, 
and efforts in precision medicine, which aim to find the right drugs for the right patients at the 
right time. There is a growing realization that genomics is only a part of the story when it comes 
to cancer and other complex diseases. The field is working to augment genetic information 
(mutations, deletions, and other somatic genetic alterations) with other omics data, such as 
epigenomics (methylation, non-coding RNAs, histone modifications, chromatin structures), 
proteomics (in vitro studies on proteins), and lipidomics (survey of cellular lipids), to name a 
few. The network medicine framework presents a promising way of thinking about and 
integrating these heterogeneous data types by elucidating their mutual influences to help 
explain disease etiologies and cellular functions and providing the basis for personalized 
therapeutics.  
Multi-omics data integration using networks has already started gaining a wide amount of 
attention in the scientific community (Gligorijevic and Przulj, 2015; Hasin et al., 2017; Huang 
et al., 2017; Tuncbag et al., 2016; Yugi et al., 2016). Moreover, relatively newer network tools 
like multiplex networks (Didier et al., 2018), network fusion (Wang et al., 2014), more 
innovative community detection strategies (Gligorijevic et al., 2016), higher order structural 
modularity (Didier et al., 2018), have the potential to be applied to these problems to gain an 
even deeper and more nuance understanding of biological systems. Multilayer network 
approaches (De Domenico et al., 2015) for human diseases have unraveled important 
associations between rare and complex diseases (Halu et al., 2017). Despite several open 
challenges (Stegle et al., 2015; Ziegenhain et al., 2017), new technologies like single-cell 
transcriptomics (Hon et al., 2018), have started to be used to construct GRNs (Fiers et al., 2018; 
Herbach et al., 2017) and cell-specific coactivation networks (Ghazanfar et al., 2016). As the 
field of network medicine moves forward, one thing that is required more than ever before is 
the development of methods for systematically validating network predictions. Such validation 
will provide a greater confidence in network predictions and facilitate their incorporation into 
translational medicine. We also think active trans-disciplinary collaboration between biologists 
and scientists from the field of complex networks is required to infuse the field of network 
medicine with novel algorithms and innovative strategies. The application of network methods 
to biomedical data presents a great opportunity to test and improve upon the tools originating 
from the general field of complex networks. We also take this opportunity to thank the many 
experimental biologists whose operose efforts have led to the generation of the vast amount of 
invaluable biomedical data, and to the numerous individuals who have donated their data for 
the sake of science. 
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Figure legends: 
Figure 1: Overview of network medicine approach depicting various biomedical data types 
discussed at length in the manuscript, along with network representations that simplify 
different components of multiple omics data from the genome, transcriptome, proteome, and 
metabolome as nodes that are connected by links (edges). Combining biomedical data with the 
appropriate network modeling approach allows derivation of disease associated information 
and outcomes like biomarkers, therapeutics targets, phenotype-specific genes and interactions, 
and disease subtypes.  
 
Figure 2: Schematic of three paradigms for combining biological networks with phenotype-
specific biomedical data, such as a set of disease genes and transcriptomic profiles for case and 
control groups. (a) Identification of disease associated network components within the 
interactome, (b) Co-expression based network modeling to identify disease biomarkers, (c) 
Constructing phenotype-specific GRNs to identify perturbations and condition-specific 
regulatory changes. 
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